Valeant Pharmaceuticals is paying $54 million to settle kickback charges against its Salix unit.
Takeda Pharmaceutical and Theravance Biopharma entered into a global license, development and commercialization agreement.
A budget impact analysis estimated when the cost savings are amortized over one million lives, Commonwealth Laboratories’ IBSchek will save healthcare payers more than $3.5 million annually.
Cantel Medical stock saw a 7.05 percent-drop in short interest.
New research shows Allurion Technologies’ Elipse balloon is a safe and effective procedureless weight-loss treatment.
More articles on GI/endoscopy:
Cantel Medical’s short interest drops 7.05%: 3 points
Use of Allurion Technologies’ Elipse gastric balloon results in successful weight loss: 4 things to know
Healthmark adds Endo Bin & Trolley Set; enables controlled delivery & retrievable system for endoscopes
